Transition to Tenofovir, Lamivudine, Dolutegravir (TLD)

Aim: Awareness Creation of the Transition to Tenofovir, Lamivudine, Dolutegravir (TLD) as the Primary First-line Therapy and Treatment Literacy Knowledge Based on Current ART Service Guidelines for Adolescent Girls and Young Women Living with HIV/AIDS” in the Dar Es Salaam Region.
Location: Kinondoni, Temeke, Ubungo, Kigamboni and Ilala Districts
Period: 2020-2021 (One year)
Donor: The US Presidents Emergency Plans for AIDS Relief (PEPFAR)
Achievements: TAYOBECO successfully reached and raised awareness to more than 5000 youth including Adolescent Girls and Young Women on the transition to Tenofovir, Lamivudine, Dolutegravir (TLD) and retained more than 600 Adolescent Girls and Young Women living with HIV who lost to follow-ups and missed ART in the 5 District Councils of the Dar es Salaam Region (Temeke, Kinondoni, Ilala, Ubungo, and Kigamboni Districts).